Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · Real-Time Price · USD
20.26
-2.28 (-10.12%)
At close: May 1, 2026, 4:00 PM EDT
20.13
-0.13 (-0.64%)
After-hours: May 1, 2026, 7:35 PM EDT
Alignment Healthcare Stock Forecast
Stock Price Forecast
The 9 analysts that cover Alignment Healthcare stock have a consensus rating of "Buy" and an average price target of $23.11, which forecasts a 14.07% increase in the stock price over the next year. The lowest target is $19 and the highest is $30.
Price Target: $23.11 (+14.07%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Alignment Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 2 |
| Buy | 6 | 6 | 6 | 6 | 6 | 4 |
| Hold | 2 | 2 | 2 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 12 | 12 | 12 | 12 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $21 → $22 | Hold | Maintains | $21 → $22 | +8.59% | May 1, 2026 |
| Barclays | Barclays | Hold Maintains $18 → $19 | Hold | Maintains | $18 → $19 | -6.22% | May 1, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $23 → $26 | Buy | Maintains | $23 → $26 | +28.33% | Feb 5, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $19 → $25 | Strong Buy | Maintains | $19 → $25 | +23.40% | Jan 16, 2026 |
| UBS | UBS | Hold Maintains $18 → $21 | Hold | Maintains | $18 → $21 | +3.65% | Jan 14, 2026 |
Financial Forecast
Revenue This Year
5.28B
from 3.95B
Increased by 33.69%
Revenue Next Year
6.59B
from 5.28B
Increased by 24.74%
EPS This Year
0.13
from -0.00
EPS Next Year
0.74
from 0.13
Increased by 454.92%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5.5B | 7.2B | |||
| Avg | 5.3B | 6.6B | |||
| Low | 5.0B | 6.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 38.0% | 36.5% | |||
| Avg | 33.7% | 24.7% | |||
| Low | 27.8% | 13.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.17 | 0.85 | |
| Avg | 0.13 | 0.74 | |
| Low | 0.05 | 0.65 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 536.0% | |
| Avg | - | 454.9% | |
| Low | - | 383.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.